C

Carisma Therapeutics

96 employees

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical
Life Science

Date founded

2016

Funding rounds raised

Total raised

$53M

from 24 investors over 24 rounds

C

Carisma Therapeutics raised $30M on September 21, 2022

Investors: Agent Capital, Wellington Partners, HealthCap, Livzon and Solasta Ventures

C

Carisma Therapeutics raised $12M on March 1, 2021

Investors: Livzon, IP Group plc, Agent Capital, Solasta Ventures and HealthCap

C

Carisma Therapeutics raised $47M on January 7, 2021

Investors: Livzon, IP Group plc, Wellington Partners, Solasta Ventures, HealthCap and Agent Capital

C

Carisma Therapeutics raised $6M on August 8, 2019

Investors: HealthCap

C

Carisma Therapeutics raised $53M on June 27, 2018

Investors: Wellington Partners, HealthCap, Agent Capital and Grazia Equity

C

Carisma Therapeutics raised undisclosed on June 12, 2017

Investors: Grazia Equity, HealthCap and IP Group plc

FAQ